Associate Chief Physician of the Department of Urology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Group Leader of the Upper Urinary Tract Ward at the West Campus, M.D., graduated from Shanghai Jiao Tong University School of Medicine in 2011. From 2018 to 2020, conducted postdoctoral research at MD Anderson Cancer Center in the United States. Primarily engaged in minimally invasive surgery and comprehensive treatment for renal tumors, renal and ureteral tumors, adrenal and retroperitoneal tumors, performing over 200 level 4 tumor surgeries annually; skilled in nephron-sparing surgery for renal tumors, percutaneous energy ablation for early-stage renal cancer, neoadjuvant therapy and surgery for advanced renal cancer; highly experienced in comprehensive treatment for hereditary and rare pathological types of renal cancer, advanced renal cancer, and refractory renal cancer. Awarded the 2024 International Kidney Cancer Coalition (IKCC) Cecile and Ken Youner Young Investigator Award; the 2023 Third "Golden Mountain Camellia Plan" People's Good Doctor (Urologic Oncology Field) National Outstanding Expert; the 2021 European Association of Urology Annual Meeting Best Research Abstract Second Prize; participated in and contributed to receiving the 2014 Shanghai Medical Science and Technology Award First Prize, the 2015 Ministry of Education Higher Education Science and Technology Progress Award First Prize, and the 2015 Huaxia Medical Science and Technology Award Second Prize; published original research articles as first or corresponding author in renowned academic journals including European Urology and Nature Communications.